🔍

Crestchem Ltd (526269)

📊 BSE: 526269 🏢 Specialty Chemicals 📢 Latest filing: 12 Aug 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Crestchem's revenue was ₹9.2 Cr (+82.5% year on year, -10.3% on the previous quarter), and net profit ₹1.0 Cr (+180.8% year on year); the operating margin was 12.9%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹9.2	+82.5%	-10.3%
Operating profit	₹1.2	+228.7%	-15.5%
Net profit	₹1.0	+180.8%	-10.6%
EPS (₹)	3.28	+180.3%	-10.6%
Operating margin	12.9%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Crestchem Ltd Approves Q1 FY27 Financial Results in 15-Minute Board Meeting

🟡 NEUTRAL ⭐ 6/10

EARNINGS 📅 12 Aug 2026, 04:51 PM

Crestchem Ltd held a board meeting on August 12, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The meeting was notably brief, concluding in just 15 minutes. While the specific P&L figures were not detailed in the cover letter, the company enters this period with a TTM revenue of Rs 30 Cr and a high ROCE of 43.4%. Investors should monitor the full results for growth relative to the March 2026 quarter's revenue of Rs 10.23 Cr.

Board meeting conducted and concluded within 15 minutes (4:30 PM to 4:45 PM) on August 12, 2026.
Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
Company maintains a debt-free balance sheet (D/E of 0.00) as per latest financial context.
TTM PAT stands at Rs 3 Cr with an operating profit margin of 10.7% leading into this result.
Promoter holding remains relatively low at 29.76% as of June 2026.

💡 Investors should examine the detailed financial tables to verify if the company sustained the sequential revenue growth seen in Mar 2026 (Rs 10.23 Cr vs Rs 7.16 Cr in Dec 2025).

Aug 12 Board Meeting to Approve Q1 Results and Address BSE Fine for Late Filing

🟡 NEUTRAL ⭐ 4/10

BOARD_MEETING 📅 07 Aug 2026, 11:32 AM

Crestchem Ltd has scheduled a board meeting on August 12, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The board will also formally note a fine imposed by the BSE for the late submission of its consolidated cash flow statement. This delay was reportedly due to the registration of a new subsidiary on March 31, 2026. Investors should monitor if the company can sustain the revenue momentum seen in Q4 FY26, where it reported sales of ₹10.23 crore.

Board meeting scheduled for August 12, 2026, at 04:30 PM to approve Q1 FY27 results.
Company to address a BSE fine regarding late submission of consolidated cash flow statements.
The reporting delay was linked to a new subsidiary registered on March 31, 2026.
Latest TTM revenue stands at ₹30 crore with a PAT of ₹3 crore.
Promoter holding remains relatively low at 29.76% as of June 2026.

💡 Watch for the Q1 FY27 earnings release on August 12 to evaluate if the operating profit margin (OPM) remains stable around the 10.8% level seen in FY26.

₹1.06 Lakh Fine Imposed by BSE for Late Filing; Company Seeking Waiver

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 04 Aug 2026, 05:13 PM

BSE Limited has notified Crestchem Ltd of an outstanding fine amounting to ₹1,06,200 for the late submission of its Consolidated Cash Flow Statement under Regulation 33. The company clarified that its subsidiary, Oleo Biosciences Private Limited, was incorporated on the very last day of the financial year (March 31, 2026) and had no financial transactions to report. Crestchem is actively seeking a waiver for this fine, arguing that there was no financial data requiring inclusion at that time. Given the company's TTM PAT of ₹3 crore, the fine is immaterial to its overall financial health.

BSE notified the company of a ₹1,06,200 fine via email on August 4, 2026.
The fine pertains to the late submission of the Consolidated Cash Flow Statement for FY26.
Subsidiary Oleo Biosciences Private Limited was incorporated on March 31, 2026, with zero transactions.
The fine amount represents approximately 0.35% of the company's TTM PAT of ₹3 crore.
The company is positive about receiving a waiver and expects no material financial impact.

💡 Investors should treat this as a routine administrative matter; watch for future filings to confirm if the BSE grants the requested waiver.

Rs 1.50 Dividend: Crestchem Sets July 30, 2026, as Record Date

🟢 POSITIVE ⭐ 5/10

DIVIDEND 📅 16 Jul 2026, 01:53 PM

Crestchem Ltd has finalized July 30, 2026, as the record date for its FY 2025-26 dividend payment. The dividend is declared at 15%, which translates to Rs 1.50 per equity share. Based on the current market price of Rs 135.5, this represents a dividend yield of approximately 1.1%. The decision follows a board meeting held on July 4, 2026.

Dividend amount fixed at Rs 1.50 per equity share
Record date for eligibility set for July 30, 2026
Dividend payout rate established at 15% of face value
Board approval for the record date was finalized on July 4, 2026

💡 Investors seeking the dividend must ensure they hold the shares before the ex-dividend date (typically one business day prior to the July 30 record date).

Rs 1.50 Dividend: Crestchem Ltd Sets Record Date and 34th AGM Schedule

🟢 POSITIVE ⭐ 5/10

DIVIDEND 📅 16 Jul 2026, 01:43 PM

Crestchem Ltd has announced a dividend of Rs 1.50 per equity share for the financial year, applicable to 30,00,000 equity shares. The record date to determine shareholder eligibility for this dividend and for e-voting at the 34th Annual General Meeting (AGM) is July 30, 2026. The AGM is scheduled for August 06, 2026, with the book closure period running from July 31 to August 06, 2026. At the current share price of Rs 135.5, the dividend yield is approximately 1.11%.

Dividend declared at Rs 1.50 per equity share for 30,00,000 shares.
Record date for dividend eligibility and e-voting is July 30, 2026.
34th Annual General Meeting (AGM) scheduled for August 06, 2026.
Book closure period set from July 31, 2026, to August 06, 2026.
Cut-off date for release of AGM Notice and Annual Report was July 10, 2026.

💡 Investors seeking the dividend must ensure they hold the shares before the record date of July 30, 2026. Monitor the AGM on August 06 for management updates on business strategy.

Crestchem Ltd Confirms Non-Applicability of Escrow Payment Mechanism

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 15 Jul 2026, 02:52 PM

Crestchem Ltd has filed a clarification with the BSE stating that the Escrow Payment Mechanism is not applicable to the company. The filing confirms the absence of several specific account types, including No Lien escrow, Interest Payment, Sinking Fund, and General accounts. This is a procedural regulatory disclosure and does not indicate any change in the company's financial position or operations. Investors should view this as a routine compliance update.

Confirmed 0 No Lien escrow accounts are maintained by the company
Confirmed 0 Interest Payment Accounts or Sinking Fund Accounts exist
Official disclosure submitted to BSE on July 15, 2026
Statement signed by Nitinkumar S. Shah, Company Secretary and Compliance Officer

💡 No action is required as this is a routine administrative filing. Investors should continue to monitor the company's quarterly financial results for operational performance.

Crestchem Ltd Confirms Non-Applicability of Escrow Payment Mechanism for Q1 FY27

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 15 Jul 2026, 02:48 PM

Crestchem Ltd has submitted its quarterly compliance report for the period ending June 2026 regarding the Escrow Payment Mechanism. The company explicitly stated that it does not maintain any No Lien escrow accounts, Interest Payment accounts, Sinking Fund accounts, or General accounts. As a result, the Escrow Payment Mechanism requirements are not applicable to the company. This is a standard procedural filing confirming the absence of specific structured debt-servicing accounts.

Company confirmed 0 active No Lien escrow accounts as of July 15, 2026
Company confirmed 0 active Interest Payment accounts
Company confirmed 0 active Sinking Fund accounts
Filing made under Regulation 57(5) for the quarter ended June 2026

💡 No action is required as this is a routine administrative filing. Investors should focus on upcoming quarterly financial results for operational performance updates.

Crestchem FY26: Income Rises 18.6% to ₹25.52 Cr; ₹1.50 Dividend & New Subsidiary Investment

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 13 Jul 2026, 03:41 PM

Crestchem Limited reported a total income of ₹25.52 Cr for FY25-26, marking an 18.6% increase from the previous year. Despite the revenue growth, net profit remained nearly flat at ₹2.71 Cr compared to ₹2.73 Cr in FY24-25. The company has proposed a final dividend of ₹1.50 per share (15%) and is seeking approval for a ₹2.75 Cr investment in its newly formed subsidiary, Oleo Biosciences Private Limited. Additionally, the company is renewing five-year management contracts for the Managing Director and Executive Director with revised remuneration.

Total Income increased to ₹25.52 Cr in FY26 from ₹21.52 Cr in FY25.
Proposed final dividend of ₹1.50 per equity share of ₹10 face value.
Planned investment of ₹2.75 Cr in the new subsidiary Oleo Biosciences Private Limited (incorporated March 2026).
Managing Director's proposed monthly salary set at ₹5,00,000 effective July 2026.
Net Profit for the year stood at ₹2.71 Cr with an EPS of ₹9.04.

💡 Investors should monitor the AGM on August 06, 2026, for the approval of the ₹2.75 Cr subsidiary investment and track the operational progress of Oleo Biosciences as a new growth lever.

View All 526269 Announcements on Live Market Tracking →